Tommi Järvinen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tommi Järvinen has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Jari Räsänen
Department of Surgery, Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland
9 shared publications- Ilkka Ilonen
Departments of Oncology and Hematology, iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
7 shared publications Ilkka Ilonen
Department of Surgery, Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland
5 shared publicationsJarmo Salo
Department of General Thoracic and Esophageal Surgery, Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland; Department of Surgery, Faculty of Medicine, University of Helsinki, Helsinki, Finland
4 shared publicationsJuha Kauppi
Department of General Thoracic and Esophageal Surgery, Helsinki University Hospital, Haartmaninkatu 4, 00290, Helsinki, Finland
4 shared publicationsHenriikka Hietaniemi
Department of Gastrointestinal Surgery, Helsinki University Hospital, Helsinki, Finland
3 shared publications
Latest Publications
- 6 October 2025
- Published by SAGE Publications in Foregut: The Journal of the American Foregut Society
- Vol. 6 (1) , 64-71
Impact of Antireflux Surgery on Interstitial Lung Disease and Lung Transplantation
Gastroesophageal reflux disease (GERD) is a prevalent problem in patients with interstitial lung disease (ILD) before or after lung transplantation. It has been linked to the pathogenesis of ILD, but the precise nature of this relationship remains unclear. Antireflux surgery has shown benefit in slowing progression of ILD in retrospective studies; however, the only randomized study was underpowered to detect a statistical difference. Lung transplantation further worsens the rates of GERD and other gastrointestinal issues by multiple mechanisms. After lung transplant, many retrospective studies show that antireflux surgery is associated with lower rates of chronic allograft dysfunction and better overall survival.
- 6 October 2025
- Published by SAGE Publications in Foregut: The Journal of the American Foregut Society
- Vol. 6 (1) , 64-71
Impact of Antireflux Surgery on Interstitial Lung Disease and Lung Transplantation
Gastroesophageal reflux disease (GERD) is a prevalent problem in patients with interstitial lung disease (ILD) before or after lung transplantation. It has been linked to the pathogenesis of ILD, but the precise nature of this relationship remains unclear. Antireflux surgery has shown benefit in slowing progression of ILD in retrospective studies; however, the only randomized study was underpowered to detect a statistical difference. Lung transplantation further worsens the rates of GERD and other gastrointestinal issues by multiple mechanisms. After lung transplant, many retrospective studies show that antireflux surgery is associated with lower rates of chronic allograft dysfunction and better overall survival.
- Open Access
- 7 February 2023
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 58 (7) , 764-770
Paraconduit hernia after minimally invasive esophagectomy – incidence and risk factors
Paraconduit hernia is a relatively common long-term complication after esophagectomy which has the potential to cause great morbidity and even mortality. The aim of this study is to examine the ris...
- 7 February 2023
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 58 (7) , 764-770
Open AccessParaconduit hernia after minimally invasive esophagectomy – incidence and risk factors
Paraconduit hernia is a relatively common long-term complication after esophagectomy which has the potential to cause great morbidity and even mortality. The aim of this study is to examine the ris...
- Open Access
- 4 June 2022
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 57 (11) , 1291-1295
Congenital diaphragmatic hernia in adults: a decade of experience from a single tertiary center
Congenital diaphragmatic hernias (CDHs) in adults remain rare, with limited data on them available. However, CDHs can cause respiratory and gastrointestinal symptoms in adults, even resulting in th...
- 4 June 2022
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 57 (11) , 1291-1295
Open AccessCongenital diaphragmatic hernia in adults: a decade of experience from a single tertiary center
Congenital diaphragmatic hernias (CDHs) in adults remain rare, with limited data on them available. However, CDHs can cause respiratory and gastrointestinal symptoms in adults, even resulting in th...
- Open Access
- 31 January 2022
- Published by Springer Nature in Research Square
Does Skeletal Muscle Loss and Sarcopenia Predispose Patients for the Development of a Paraconduit Hernia After Minimally Invasive Esophagectomy? – A Propensity Matched Case-control Study
BackgroundParaconduit hernia is a relatively common long-term complication after esophagectomy which has the potential to cause great morbidity and even mortality. The aim of this study is to examine the relationship between sarcopenia and muscle mass loss and paraconduit hernia after minimally invasive esophagectomy in esophageal adenocarcinoma patients who have received neoadjuvant treatment.MethodsAll minimally invasive esophagectomies done for patients with neoadjuvant-treated esophageal or esophagogastric junction adenocarcinoma at our institution between 2008 and 2018 were included in this study. Propensity score matching was utilized to minimize confounding effects of retrospective data analysis. Computed tomography scans were used to measure skeletal muscle mass and to quantify sarcopenia.ResultsThe incidence of paraconduit hernia was 14 out of 171 patients (8.2%). The hernia was surgically repaired in 10 (71.4%) of patients. A total of 23 (82.1%) patients in the matched group were sarcopenic before start of neoadjuvant treatments, 22 (78.6%) after neoadjuvant treatments and 24 (85.7%) at 6 months of follow-up. Skeletal muscle area, skeletal muscle index or prevalence of sarcopenia had no correlation with paraconduit hernia developement. Using the median change of skeletal muscle area between pre-neoadjuvant and 6 months follow-up visit as a threshold to divide the patients into two equal size groups yielded no significantly different survival curves using Kaplan-Meier analysis (p = 0.6).ConclusionParaconduit hernia is a relatively common complication after minimally invasive esophagectomy for neadjuvantly treated adenocarcinoma patients. Sarcopenia and muscle mass loss are not predictive factors for paraconduit hernia.
- 31 January 2022
- Published by Springer Nature in Research Square
Open AccessDoes Skeletal Muscle Loss and Sarcopenia Predispose Patients for the Development of a Paraconduit Hernia After Minimally Invasive Esophagectomy? – A Propensity Matched Case-control Study
BackgroundParaconduit hernia is a relatively common long-term complication after esophagectomy which has the potential to cause great morbidity and even mortality. The aim of this study is to examine the relationship between sarcopenia and muscle mass loss and paraconduit hernia after minimally invasive esophagectomy in esophageal adenocarcinoma patients who have received neoadjuvant treatment.MethodsAll minimally invasive esophagectomies done for patients with neoadjuvant-treated esophageal or esophagogastric junction adenocarcinoma at our institution between 2008 and 2018 were included in this study. Propensity score matching was utilized to minimize confounding effects of retrospective data analysis. Computed tomography scans were used to measure skeletal muscle mass and to quantify sarcopenia.ResultsThe incidence of paraconduit hernia was 14 out of 171 patients (8.2%). The hernia was surgically repaired in 10 (71.4%) of patients. A total of 23 (82.1%) patients in the matched group were sarcopenic before start of neoadjuvant treatments, 22 (78.6%) after neoadjuvant treatments and 24 (85.7%) at 6 months of follow-up. Skeletal muscle area, skeletal muscle index or prevalence of sarcopenia had no correlation with paraconduit hernia developement. Using the median change of skeletal muscle area between pre-neoadjuvant and 6 months follow-up visit as a threshold to divide the patients into two equal size groups yielded no significantly different survival curves using Kaplan-Meier analysis (p = 0.6).ConclusionParaconduit hernia is a relatively common complication after minimally invasive esophagectomy for neadjuvantly treated adenocarcinoma patients. Sarcopenia and muscle mass loss are not predictive factors for paraconduit hernia.
- Open Access
- 17 November 2021
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 14 (6) , 2335-2339
General thoracic surgery in Finland, a perspective from the Helsinki University Hospital
The field of thoracic surgery is a rapidly developing field due to exciting developments in technology and oncologic treatments as well as continuous innovation in surgical technique. Although the population of Finland is relatively small, general thoracic surgery is represented at a high level in five centralized university centers, Helsinki University Hospital, Tampere University Hospital, Turku University Hospital, Kuopio University Hospital and Oulu University Hospital. Thus, high case volume and good results are achieved in these centers. Here, we describe a short history, current state and future prospects of the field of cardiothoracic surgery in Finland, with a focus on general thoracic surgery and the perspective of Helsinki University Hospital. From the field's birth in Finland, marked by the first lobectomy, in the late 1930's, it has grown and adapted more and more modern techniques such as totally minimally invasive esophagectomy and robotic lung cancer surgery. Nowadays, most of general thoracic surgery in Helsinki University Hospital is either minimally invasive or robotic and open surgery is the exception to the norm. Helsinki University Hospital has a strong presence in the European general thoracic surgery community and aims to do so in the future by investing on training & education, research and surgical innovation.
- 17 November 2021
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 14 (6) , 2335-2339
Open AccessGeneral thoracic surgery in Finland, a perspective from the Helsinki University Hospital
The field of thoracic surgery is a rapidly developing field due to exciting developments in technology and oncologic treatments as well as continuous innovation in surgical technique. Although the population of Finland is relatively small, general thoracic surgery is represented at a high level in five centralized university centers, Helsinki University Hospital, Tampere University Hospital, Turku University Hospital, Kuopio University Hospital and Oulu University Hospital. Thus, high case volume and good results are achieved in these centers. Here, we describe a short history, current state and future prospects of the field of cardiothoracic surgery in Finland, with a focus on general thoracic surgery and the perspective of Helsinki University Hospital. From the field's birth in Finland, marked by the first lobectomy, in the late 1930's, it has grown and adapted more and more modern techniques such as totally minimally invasive esophagectomy and robotic lung cancer surgery. Nowadays, most of general thoracic surgery in Helsinki University Hospital is either minimally invasive or robotic and open surgery is the exception to the norm. Helsinki University Hospital has a strong presence in the European general thoracic surgery community and aims to do so in the future by investing on training & education, research and surgical innovation.
- Open Access
- 28 July 2021
- Published by Elsevier in JTCVS Open
- Vol. 7, 338-352
Hand-sewn versus stapled anastomoses for esophagectomy: We will probably never know which is better
- 28 July 2021
- Published by Elsevier in JTCVS Open
- Vol. 7, 338-352
Open AccessHand-sewn versus stapled anastomoses for esophagectomy: We will probably never know which is better
- Open Access
Hyperthermic Intrathoracic Chemoperfusion for Malignant Pleural Mesothelioma: Systematic Review and Meta-Analysis
Malignant pleural mesothelioma (MPM) is an aggressive malignancy of the pleural lining with exceptionally poor survival. Hyperthermic intrathoracic chemoperfusion (HITHOC) is commonly used with surgery in limited disease. However, data on its effect on survival are limited. In this systematic review and meta-analysis, we analyzed a total of 11 observational articles. HITHOC was compared to control arm that did not receive HITHOC in three studies including 762 patients. The pooled analysis of these studies revealed an SMD of 0.24, with 95% CI of 0.06–0.41 favoring the HITHOC group, reaching statistical significance. The survival effect of HITHOC in epithelioid MPM vs. non-epithelioid MPM was analyzed in four studies. Pooled analysis showed an SMD of 0.79 (95% CI = 0.48–1.10) favoring epithelioid MPM. Based on available data, there seems to be a benefit with HITHOC in regards to overall survival in the treatment of all mesothelioma patients. Multicenter randomized controlled trials are needed to validate and standardize this treatment approach.
Open AccessHyperthermic Intrathoracic Chemoperfusion for Malignant Pleural Mesothelioma: Systematic Review and Meta-Analysis
Malignant pleural mesothelioma (MPM) is an aggressive malignancy of the pleural lining with exceptionally poor survival. Hyperthermic intrathoracic chemoperfusion (HITHOC) is commonly used with surgery in limited disease. However, data on its effect on survival are limited. In this systematic review and meta-analysis, we analyzed a total of 11 observational articles. HITHOC was compared to control arm that did not receive HITHOC in three studies including 762 patients. The pooled analysis of these studies revealed an SMD of 0.24, with 95% CI of 0.06–0.41 favoring the HITHOC group, reaching statistical significance. The survival effect of HITHOC in epithelioid MPM vs. non-epithelioid MPM was analyzed in four studies. Pooled analysis showed an SMD of 0.79 (95% CI = 0.48–1.10) favoring epithelioid MPM. Based on available data, there seems to be a benefit with HITHOC in regards to overall survival in the treatment of all mesothelioma patients. Multicenter randomized controlled trials are needed to validate and standardize this treatment approach.
- Open Access
- 20 May 2020
- Published by Springer Nature in BMC Surgery
- Vol. 20 (1) , 109
Health-related quality of life after laparoscopic repair of giant paraesophageal hernia: how does recurrence in CT scan compare to clinical success?
Background: Computed tomography (CT) is widely used in the diagnosis of giant paraesophageal hernias (GPEH) but has not been utilised systematically for follow-up. We performed a cross-sectional observational study to assess mid-term outcomes of elective laparoscopic GPEH repair. The primary objective of the study was to evaluate the radiological hernia recurrence rate by CT and to determine its association with current symptoms and quality of life. Methods: All non-emergent laparoscopic GPEH repairs between 2010 to 2015 were identified from hospital medical records. Each patient was offered non-contrast CT and sent questionnaires for disease-specific symptoms and health-related quality of life. Results: The inclusion criteria were met by 165 patients (74% female, mean age 67 years). Total recurrence rate was 29.3%. Major recurrent hernia (> 5 cm) was revealed by CT in 4 patients (4.3%). Radiological findings did not correlate with symptom-related quality of life. Perioperative mortality occurred in 1 patient (0.6%). Complications were reported in 27 patients (16.4%). Conclusions: Successful laparoscopic repair of GPEH requires both expertise and experience. It appears to lead to effective symptom relief with high patient satisfaction. However, small radiological recurrences are common but do not affect postoperative symptom-related patient wellbeing.
- 20 May 2020
- Published by Springer Nature in BMC Surgery
- Vol. 20 (1) , 109
Open AccessHealth-related quality of life after laparoscopic repair of giant paraesophageal hernia: how does recurrence in CT scan compare to clinical success?
Background: Computed tomography (CT) is widely used in the diagnosis of giant paraesophageal hernias (GPEH) but has not been utilised systematically for follow-up. We performed a cross-sectional observational study to assess mid-term outcomes of elective laparoscopic GPEH repair. The primary objective of the study was to evaluate the radiological hernia recurrence rate by CT and to determine its association with current symptoms and quality of life. Methods: All non-emergent laparoscopic GPEH repairs between 2010 to 2015 were identified from hospital medical records. Each patient was offered non-contrast CT and sent questionnaires for disease-specific symptoms and health-related quality of life. Results: The inclusion criteria were met by 165 patients (74% female, mean age 67 years). Total recurrence rate was 29.3%. Major recurrent hernia (> 5 cm) was revealed by CT in 4 patients (4.3%). Radiological findings did not correlate with symptom-related quality of life. Perioperative mortality occurred in 1 patient (0.6%). Complications were reported in 27 patients (16.4%). Conclusions: Successful laparoscopic repair of GPEH requires both expertise and experience. It appears to lead to effective symptom relief with high patient satisfaction. However, small radiological recurrences are common but do not affect postoperative symptom-related patient wellbeing.
- Open Access
- 1 May 2020
- Published by Elsevier in Clinical Lung Cancer
- Vol. 21 (3) , e142-e150
Elevated Circulating Activin A Levels in Patients With Malignant Pleural Mesothelioma Are Related to Cancer Cachexia and Reduced Response to Platinum-based Chemotherapy
- 1 May 2020
- Published by Elsevier in Clinical Lung Cancer
- Vol. 21 (3) , e142-e150
Open AccessElevated Circulating Activin A Levels in Patients With Malignant Pleural Mesothelioma Are Related to Cancer Cachexia and Reduced Response to Platinum-based Chemotherapy